Anthony Boral
2017
In 2017, Anthony Boral earned a total compensation of $1.7M as Chief Medical Officer at Blueprint Medicines, a 78% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $162,551 |
|---|---|
| Option Awards | $1,082,376 |
| Salary | $411,000 |
| Other | $8,100 |
| Total | $1,664,027 |
Boral received $1.1M in option awards, accounting for 65% of the total pay in 2017.
Boral also received $162.6K in non-equity incentive plan, $411K in salary and $8.1K in other compensation.
Rankings
In 2017, Anthony Boral's compensation ranked 6,444th out of 14,666 executives tracked by ExecPay. In other words, Boral earned more than 56.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,444 out of 14,666 | 56th |
Division Manufacturing | 2,374 out of 5,772 | 59th |
Major group Chemicals And Allied Products | 755 out of 2,075 | 64th |
Industry group Drugs | 583 out of 1,731 | 66th |
Industry Pharmaceutical Preparations | 461 out of 1,333 | 65th |
Source: SEC filing on April 27, 2018.
Boral's colleagues
We found six more compensation records of executives who worked with Anthony Boral at Blueprint Medicines in 2017.
2017
Jeffrey Albers
Blueprint Medicines
Chief Executive Officer
2017
Christopher Murray
Blueprint Medicines
Senior Vice President, Technical Operations
2017
Kathryn Haviland
Blueprint Medicines
Chief Operating Officer
2017
Kate Haviland
Blueprint Medicines
Chief Business Officer
2017
Michael Landsittel
Blueprint Medicines
Vice President, Finance
2017
Tracey McCain
Blueprint Medicines